Stockhead TV
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Chimeric Therapeutics.
RELATED STOCKHEAD STORIES
Health & Biotech
Health Check: Hearts are pumping as Anteris shares debut on the Nasdaq
Health & Biotech
Dr Boreham’s Crucible: Can this cancer drug developer hit right notes for commercial success?
News
ASX Small Caps Lunch Wrap: ASX claws back early losses after sluggish start
News
Top 10 at 11: Drug trial progress and coal success are today’s news
Health & Biotech
Health Check: Latest biotech quarterly results are as patchy as the curate’s egg
Health & Biotech
Health Check: Thirsty Chimeric goes to the well for funding top-up
Health & Biotech
Health Check: Cancer drug developer Chimeric heads to blood bank for better patient cells
Health & Biotech
ASX Health Stocks: Telix’s brain-cancer imaging agent Pixclara handed to FDA for review
Health & Biotech
ASX Health Stocks: Lift off for LTR Pharma’s ED therapy under TGA scheme
Investor Guides
Investor Guide: Health & Biotech FY2025 featuring Tim Boreham
Health & Biotech
ASX Health Stocks: Immutep gets positive FDA feedback for lung cancer therapy
Health & Biotech
ASX Health Stocks: Health app firm MedAdvisor guides the market to record year and maiden profit
News
Closing Bell: ASX rides high as gold, silver, copper, and iron ore surge; Nuix jumps 25pc
Health & Biotech
ASX Health Stocks: Memphasys’ Felix triumphs over traditional sperm-prepping methods for IVF
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX phones in more gains as prices plunge in Beijing and records tumble in New York
News
